Current standing and future prospects for the technologies proposed to transform toxicity testing in the 21st century

Altex

Volumn 28, Issue 1, 2011, Pages 17-44

  Van Vliet, Erwin ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

High throughput; Imaging; In vitro toxicology; Omics; Stem cells; Systems biology; Testing strategies

Indexed keywords

CAENORHABDITIS ELEGANS; CARDIOTOXICITY; CELL CULTURE; CENTRAL NERVOUS SYSTEM; DROSOPHILA MELANOGASTER; DRUG INDUCED DISEASE; EMBRYONIC STEM CELL; FEASIBILITY STUDY; GENOMICS; HIGH THROUGHPUT SCREENING; HUMAN; IN VITRO STUDY; KIDNEY; LIVER; LIVER TOXICITY; METABOLOMICS; MOLECULAR IMAGING; NONHUMAN; PLURIPOTENT STEM CELL; PROTEOMICS; REVIEW; RISK ASSESSMENT; SKIN; STEM CELL; TOXICITY TESTING; TOXICOGENETICS; ZEBRA FISH; ANIMAL; ANIMAL TESTING ALTERNATIVE; METHODOLOGY; PRODUCT SAFETY;

ANIMAL TESTING ALTERNATIVES; ANIMALS; CELLS, CULTURED; CONSUMER PRODUCT SAFETY; HUMANS; TOXICITY TESTS;

EID: 79958288447     PISSN: 09467785     EISSN: None     Source Type: Journal    
DOI: 10.14573/altex.2011.1.017     Document Type: Review

References (323)

1. Aardema, M. J. and MacGregor, J. T. (2002). Toxicology and genetic toxicology in the new era of "toxicogenomics": impact of "-omics" technologies. Mutat. Res. 499, 13-25. (Pubitemid 34137071)
2. Abraham, V. C., Towne, D. L., Waring, J. F. et al. (2008). Application of a high-content multiparameter cytotoxicity assay to prioritize compounds based on toxicity potential in humans. J. Biomol. Screen 13, 527-537. (Pubitemid 351905075)
3. Aderem, A. (2005). Systems biology: its practice and challenges. Cell 121, 511-513.
4. Agarwal, S., Holton, K. L. and Lanza, R. (2008). Efficient differentiation of functional hepatocytes from human embryonic stem cells. Stem Cells 26, 1117-1127.
5. Alepee, N., Tornier, C., Robert, C. et al. (2010). A catch-up validation study on reconstructed human epidermis (SkinEthic RHE) for full replacement of the Draize skin irritation test. Toxicol. In Vitro 24, 257-266.
6. st century: bringing the vision to life. Toxicol. Sci. 107, 324-330.
7. Anderson, G. L., Cole, R. D. and Williams, P. L. (2004). Assessing behavioral toxicity with Caenorhabditis elegans. Environ. Toxicol. Chem. 23, 1235-1240. (Pubitemid 38621028)
8. Aschner, M. and Kimelberg, H. K. (1991). The use of astrocytes in culture as model systems for evaluating neurotoxic-induced-injury. Neurotoxicology 12, 505-517.
9. Asha, S. and Vidyavathi, M. (2010). Role of human liver microsomes in in vitro metabolism of drugs-a review. Appl. Biochem. Biotechnol. 160, 1699-1722.
10. Astin, J. W., O'Neil, N. J. and Kuwabara, P. E. (2008). Nucleotide excision repair and the degradation of RNA pol II by the Caenorhabditis elegans XPA and Rsp5 orthologues, RAD-3 and WWP-1. DNA Repair (Amst.) 7, 267-280.
11. Baer, P. C., Bereiter-Hahn, J., Schubert, R. et al. (2006). Differentiation status of human renal proximal and distal tubular epithelial cells in vitro: Differential expression of characteristic markers. Cells Tissues Organs 184, 16-22. (Pubitemid 46018612)
12. Baharvand, H., Hashemi, S. M. and Shahsavani, M. (2008). Differentiation of human embryonic stem cells into functional hepatocyte-like cells in a serum-free adherent culture condition. Differentiation 76, 465-477. (Pubitemid 351725840)
13. Bakand, S., Winder, C., Khalil, C. et al. (2005). Toxicity assessment of industrial chemicals and airborne contaminants: transition from in vivo to in vitro test methods: a review. Inhal. Toxicol. 17, 775-787. (Pubitemid 41504537)
14. Balls, M. (1998). Mechanistic approaches and the development of alternative toxicity test methods. Environ. Health Perspect. 106, Suppl. 2, 453-457.
15. Basma, H., Soto-Gutierrez, A., Yannam, G. R. et al. (2009). Differentiation and transplantation of human embryonic stem cell-derived hepatocytes. Gastroenterology 136, 990-999.
16. Bilen, J. and Bonini, N. M. (2005). Drosophila as a model for human neurodegenerative disease. Annu. Rev. Genet. 39, 153-171. (Pubitemid 43011111)
17. Bird, S. D., Doevendans, P. A., van Rooijen, M. A. et al. (2003). The human adult cardiomyocyte phenotype. Cardiovasc. Res. 58, 423-434. (Pubitemid 36570400)
18. Bistola, V., Nikolopoulou, M., Derventzi, A. et al. (2008). Long-term primary cultures of human adult atrial cardiac myocytes: cell viability, structural properties and BNP secretion in vitro. Int. J. Cardiol. 131, 113-122.
19. Blackstock, W. P. and Weir, M. P. (1999). Proteomics: quantitative and physical mapping of cellular proteins. Trends Biotechnol. 17, 121-127. (Pubitemid 29348464)
20. Bongso, A., Fong, C. Y., Ng, S. C. et al. (1994). Isolation and culture of inner cell mass cells from human blastocysts. Hum. Reprod. 9, 2110-2117. (Pubitemid 24354458)
21. Bottini, A. A. and Hartung, T. (2009). Food for thought ... on the economics of animal testing. ALTEX 26, 3-16.
22. Bouvier d'Yvoire, M., Prieto, P., Blaauboer, B. J. et al. (2007). Physiologically-based Kinetic Modelling (PBK Modelling): meeting the 3Rs agenda. The report and recommendations of ECVAM Workshop 63. ATLA 35, 661-671. (Pubitemid 351169738)
23. Boyd, W. A., McBride, S. J. and Freedman, J. H. (2007). Effects of genetic mutations and chemical exposures on Caenorhabditis elegans feeding: evaluation of a novel, high-throughput screening assay. PLoS One 2, e1259.
24. Bozina, N., Bradamante, V. and Lovric, M. (2009). Genetic polymorphism of metabolic enzymes P450 (CYP) as a susceptibility factor for drug response, toxicity, and cancer risk. Arh. Hig. Rada Toksikol. 60, 217-242.
25. Braam, S. R., Tertoolen, L., van de Stolpe, A. et al. (2010). Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes. Stem Cell Res. 4, 107-116.
26. Bracken, M. B. (2009). Why animal studies are often poor predictors of human reactions to exposure. J. R. Soc. Med. 102, 120-122.
27. Breier, J. M., Gassmann, K., Kayser, R. et al. (2010). Neural progenitor cells as models for high-throughput screens of developmental neurotoxicity: state of the science. Neurotoxicol. Teratol. 32, 4-15.
28. Brolen, G., Sivertsson, L., Bjorquist, P. et al. (2010). Hepatocyte-like cells derived from human embryonic stem cells specifically via definitive endoderm and a progenitor stage. J. Biotechnol. 145, 284-294.
29. Brophy, C. M., Luebke-Wheeler, J. L., Amiot, B. P. et al. (2009). Rat hepatocyte spheroids formed by rocked technique maintain differentiated hepatocyte gene expression and function. Hepatology 49, 578-586.
30. Brown, C. D., Sayer, R., Windass, A. S. et al. (2008). Characterisation of human tubular cell monolayers as a model of proximal tubular xenobiotic handling. Toxicol. Appl. Pharmacol. 233, 428-438.
31. Bucher, J. R. (2002). The National Toxicology Program rodent bioassay: designs, interpretations, and scientific contributions. Ann. N. Y. Acad. Sci. 982, 198-207.
32. Buesen, R., Genschow, E., Slawik, B. et al. (2009). Embryonic stem cell test remastered: comparison between the validated EST and the new molecular FACS-EST for assessing developmental toxicity in vitro. Toxicol. Sci. 108, 389-400.
33. Burns, C. G., Milan, D. J., Grande, E. J. et al. (2005). High-throughput assay for small molecules that modulate zebrafish embryonic heart rate. Nat. Chem. Biol. 1, 263-264.
34. st century: a view from the chemical industry. Toxicol. Sci. 112, 297-302.
35. Butcher, E. C., Berg, E. L. and Kunkel, E. J. (2004). Systems biology in drug discovery. Nat. Biotechnol. 22, 1253-1259. (Pubitemid 39336778)
36. Buzanska, L., Sypecka, J., Nerini-Molteni, S. et al. (2009). A human stem cell-based model for identifying adverse effects of organic and inorganic chemicals on the developing nervous system. Stem Cells 27, 2591-2601.
37. Cali, J. J., Niles, A., Valley, M. P. et al. (2008). Bioluminescent assays for ADMET. Expert Opin. Drug Metab. Toxicol. 4, 103-120. (Pubitemid 351234104)
38. Camano, S., Lazaro, A., Moreno-Gordaliza, E. et al. (2010). Cilastatin attenuates cisplatin-induced proximal tubular cell damage. J. Pharmacol. Exp. Ther. 334, 419-429.
39. Cannon, C. L., Neal, P. J., Southee, J. A. et al. (1994). New epidermal model for dermal irritancy testing. Toxicol. In Vitro 8, 889-891. (Pubitemid 24312806)
40. Carere, A., Stammati, A. and Zucco, F. (2002). In vitro toxicology methods: impact on regulation from technical and scientific advancements. Toxicol. Lett. 127, 153-160. (Pubitemid 34615505)
41. Carlson, T. J. and Fisher, M. B. (2008). Recent advances in high throughput screening for ADME properties. Comb. Chem. High Throughput Screen. 11, 258-264. (Pubitemid 351480898)
42. Carpenter, A. E. and Sabatini, D. M. (2004). Systematic genome-wide screens of gene function. Nat. Rev. Genet. 5, 11-22. (Pubitemid 38055332)
43. Caspi, O., Itzhaki, I., Kehat, I. et al. (2009). In vitro electrophysiological drug testing using human embryonic stem cell derived cardiomyocytes. Stem Cells Dev. 18, 161-172.
44. Cezar, G. G., Quam, J. A., Smith, A. M. et al. (2007). Identification of small molecules from human embryonic stem cells using metabolomics. Stem Cells Dev. 16, 869-882.
45. Chaerkady, R., Kerr, C. L., Marimuthu, A. et al. (2009). Temporal analysis of neural differentiation using quantitative proteomics. J. Proteome Res. 8, 1315-1326.
46. Chalfie, M., Tu, Y., Euskirchen, G. et al. (1994). Green fluorescent protein as a marker for gene expression. Science 263, 802-805. (Pubitemid 24093206)
47. Chan, P. K., Lin, C. C. and Cheng, S. H. (2009). Noninvasive technique for measurement of heartbeat regularity in zebrafish (Danio rerio) embryos. BMC Biotechnol. 9, 11.
48. st century. Toxicol. Sci. 112, 17-22.
49. Charbit, B., Alvarez, J. C., Dasque, E. et al. (2008). Droperidol and ondansetron-induced QT interval prolongation: a clinical drug interaction study. Anesthesiology 109, 206-212.
50. Chin, M. H., Mason, M. J., Xie, W. et al. (2009). Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 5, 111-123.
51. Chivu, M., Dima, S. O., Stancu, C. I. et al. (2009). In vitro hepatic differentiation of human bone marrow mesenchymal stem cells under differential exposure to liver-specific factors. Transl. Res. 154, 122-132.
52. Cho, S. Y., Lee, E. Y., Kim, H. Y. et al. (2008). Protein profiling of human plasma samples by two-dimensional electrophoresis. Methods Mol. Biol. 428, 57-75.
53. Choi, K. D., Yu, J., Smuga-Otto, K. et al. (2009). Hematopoietic and endothelial differentiation of human induced pluripotent stem cells. Stem Cells 27, 559-567.
54. Chung, S., Sonntag, K. C., Andersson, T. et al. (2002). Genetic engineering of mouse embryonic stem cells by Nurr1 enhances differentiation and maturation into dopaminergic neurons. Eur. J. Neurosci. 16, 1829-1838. (Pubitemid 37059571)
55. Clarke, D. L., Johansson, C. B., Wilbertz, J. et al. (2000). Generalized potential of adult neural stem cells. Science 288, 1660-1663. (Pubitemid 30387435)
56. Coecke, S., Ahr, H., Blaauboer, B. J. et al. (2006). Metabolism: a bottleneck in in vitro toxicological test development. The report and recommendations of ECVAM workshop 54. ATLA 34, 49-84. (Pubitemid 43374071)
57. Coecke, S., Goldberg, A. M., Allen, S. et al. (2007). Workgroup report: incorporating in vitro alternative methods for developmental neurotoxicity into international hazard and risk assessment strategies. Environ. Health Perspect. 115, 924-931. (Pubitemid 46902248)
58. Cole, R. D., Anderson, G. L. and Williams, P. L. (2004). The nematode Caenorhabditis elegans as a model of organophosphate-induced mammalian neurotoxicity. Toxicol. Appl. Pharmacol. 194, 248-256. (Pubitemid 38175287)
59. Collins, F. S., Morgan, M. and Patrinos, A. (2003). The Human Genome Project: lessons from large-scale biology. Science 300, 286-290. (Pubitemid 36433711)
60. Collins, F. S., Gray, G. M. and Bucher, J. R. (2008). Toxicology. Transforming environmental health protection. Science 319, 906-907. (Pubitemid 351263750)
61. Creton, R. (2009). Automated analysis of behavior in zebrafish larvae. Behav. Brain Res. 203, 127-136.
62. Cronin, M. T., Jaworska, J. S., Walker, J. D. et al. (2003). Use of QSARs in international decision-making frameworks to predict health effects of chemical substances. Environ. Health Perspect. 111, 1391-1401. (Pubitemid 37021144)
63. Cronin, C. J., Feng, Z. and Schafer, W. R. (2006). Automated imaging of C. elegans behavior. Methods Mol. Biol. 351, 241-251.
64. Cubeddu, L. X. (2003). QT prolongation and fatal arrhythmias: a review of clinical implications and effects of drugs. Am. J. Ther. 10, 452-457.
65. Cuperlovic-Culf, M., Barnett, D. A., Culf, A. S. et al. (2010). Cell culture metabolomics: applications and future directions. Drug Discov. Today 15, 610-621.
66. Curren, R. D., Mun, G. C., Gibson, D. P. et al. (2006). Development of a method for assessing micronucleus induction in a 3D human skin model (EpiDerm). Mutat. Res. 607, 192-204. (Pubitemid 44107786)
67. Dash, A., Inman, W., Hoffmaster, K. et al. (2009). Liver tissue engineering in the evaluation of drug safety. Expert Opin. Drug Metab. Toxicol. 5, 1159-1174.
68. Dettmer, K., Aronov, P. A. and Hammock, B. D. (2007). Mass spectrometry-based metabolomics. Mass Spectrom. Rev. 26, 51-78. (Pubitemid 46051813)
69. Dhawan, R., Dusenbery, D. B. and Williams, P. L. (1999). Comparison of lethality, reproduction, and behavior as toxicological endpoints in the nematode Caenorhabditis elegans. J. Toxicol. Environ. Health A 58, 451-462.
70. Diaz, D., Scott, A., Carmichael, P. et al. (2007). Evaluation of an automated in vitro micronucleus assay in CHO-K1 cells. Mutat. Res. 630, 1-13. (Pubitemid 46756387)
71. Dix, D. J., Houck, K. A., Martin, M. T. et al. (2007). The ToxCast program for prioritizing toxicity testing of environmental chemicals. Toxicol. Sci. 95, 5-12. (Pubitemid 44942773)
72. Du, W., Wang, Y., Luo, Q. et al. (2006). Optical molecular imaging for systems biology: from molecule to organism. Anal. Bioanal. Chem. 386, 444-457. (Pubitemid 44450926)
73. Duggan, D. J., Bittner, M., Chen, Y. et al. (1999). Expression profiling using cDNA microarrays. Nat. Genet. 21, 10-14. (Pubitemid 29031485)
74. Ebbels, T. M., Keun, H. C., Beckonert, O. P. et al. (2007). Prediction and classification of drug toxicity using probabilistic modeling of temporal metabolic data: the consortium on metabonomic toxicology screening approach. J. Proteome Res. 6, 4407-4422. (Pubitemid 350158516)
75. Eddins, D., Cerutti, D., Williams, P. et al. (2010). Zebrafish provide a sensitive model of persisting neurobehavioral effects of developmental chlorpyrifos exposure: comparison with nicotine and pilocarpine effects and relationship to dopamine deficits. Neurotoxicol. Teratol. 32, 99-108.
76. Eimon, P. M. and Rubinstein, A. L. (2009). The use of in vivo zebrafish assays in drug toxicity screening. Expert. Opin. Drug Metab. Toxicol. 5, 393-401.
77. Elbashir, S. M., Harborth, J., Weber, K. et al. (2002). Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods 26, 199-213. (Pubitemid 34969582)
78. Eskes, C., Juillerat-Jeanneret, L., Leuba, G. et al. (2003). Involvement of microglia-neuron interactions in the tumor necrosis factor-alpha release, microglial activation, and neurodegeneration induced by trimethyltin. J. Neurosci. Res. 71, 583-590. (Pubitemid 36163341)
79. European Commission (2006). Regulation (EC) of No 1907/2006 of the European parliament and of the council 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC.
80. Evans, G. A. (2000). Designer science and the "omic" revolution. Nat. Biotechnol. 18, 127.
81. Fan, C. Y., Cowden, J., Simmons, S. O. et al. (2010). Gene expression changes in developing zebrafish as potential markers for rapid developmental neurotoxicity screening. Neurotoxicol. Teratol. 32, 91-98.
82. Farzaneh, Z., Pournasr, B., Ebrahimi, M. et al. (2010). Enhanced functions of human embryonic stem cell-derived hepatocyte-like cells on three-dimensional nanofibrillar surfaces. Stem Cell Rev. 6, 601-610.
83. Fentem, J. H., Archer, G. E., Balls, M. et al. (1998). The EC-VAM international validation study on in vitro tests for skin corrosivity. 2. results and evaluation by the management team. Toxicol. In Vitro 12, 483-524. (Pubitemid 28352758)
84. Fernandes, K. J., McKenzie, I. A., Mill, P. et al. (2004). A dermal niche for multipotent adult skin-derived precursor cells. Nat. Cell Biol. 6, 1082-1093. (Pubitemid 39468009)
85. Fernandes, T. G., Diogo, M. M., Clark, D. S. et al. (2009). High-throughput cellular microarray platforms: applications in drug discovery, toxicology and stem cell research. Trends Biotechnol. 27, 342-349.
86. Fernandez-Suarez, M. and Ting, A. Y. (2008). Fluorescent probes for super-resolution imaging in living cells. Nat. Rev. Mol. Cell Biol. 9, 929-943.
87. Ferrer-Dufol, A. and Menao-Guillen, S. (2009). Toxicogenomics and clinical toxicology: an example of the connection between basic and applied sciences. Toxicol. Lett. 186, 2-8.
88. Fletcher, S. T. and Basketter, D. A. (2006). Proteomic analysis of the response of EpiDerm cultures to sodium lauryl sulphate. Toxicol. In Vitro 20, 975-985. (Pubitemid 43949335)
89. Forsby, A. and Blaauboer, B. (2007). Integration of in vitro neurotoxicity data with biokinetic modelling for the estimation of in vivo neurotoxicity. Hum. Exp. Toxicol. 26, 333-338. (Pubitemid 46733356)
90. Forsby, A., Bal-Price, A. K., Camins, A. et al. (2009). Neuronal in vitro models for the estimation of acute systemic toxicity. Toxicol. In Vitro 23, 1564-1569.
91. Frangioni, J. V. (2003). In vivo near-infrared fluorescence imaging. Curr. Opin. Chem. Biol. 7, 626-634.
92. Gao, Y., Holland, R. D. and Yu, L. R. (2009). Quantitative proteomics for drug toxicity. Brief Funct. Genomic Proteomic 8, 158-166.
93. Garbis, S., Lubec, G. and Fountoulakis, M. (2005). Limitations of current proteomics technologies. J. Chromatogr. A 1077, 1-18.
94. Garte, S., Taioli, E., Popov, T. et al. (2008). Genetic susceptibility to benzene toxicity in humans. J. Toxicol. Environ. Health A 71, 1482-1489.
95. Gatzidou, E. T., Zira, A. N. and Theocharis, S. E. (2007). Toxicogenomics: a pivotal piece in the puzzle of toxicological research. J. Appl. Toxicol. 27, 302-309. (Pubitemid 47066756)
96. Gaudio, E., Carpino, G., Cardinale, V. et al. (2009). New insights into liver stem cells. Dig. Liver Dis. 41, 455-462.
97. Genschow, E., Scholz, G., Brown, N. et al. (2000). Development of prediction models for three in vitro embryotoxicity tests in an ECVAM validation study. In Vitr. Mol. Toxicol. 13, 51-66.
98. Genschow, E., Spielmann, H., Scholz, G. et al. (2004). Validation of the embryonic stem cell test in the international ECVAM validation study on three in vitro embryotoxicity tests. ATLA 32, 209-244. (Pubitemid 39517737)
99. George, J., Singh, R., Mahmood, Z. et al. (2010). Toxicoproteomics: new paradigms in toxicology research. Toxicol. Mech. Methods 20, 415-423.
100. Gheysens, O. and Mottaghy, F. M. (2009). Method of bioluminescence imaging for molecular imaging of physiological and pathological processes. Methods 48, 139-145.
101. Giles, A. C. and Rankin, C. H. (2009). Behavioral and genetic characterization of habituation using Caenorhabditis elegans. Neurobiol. Learn Mem. 92, 139-146.
102. Giordano, G., Kavanagh, T. J. and Costa, L. G. (2009). Mouse cerebellar astrocytes protect cerebellar granule neurons against toxicity of the polybrominated diphenyl ether (PBDE) mixture DE-71. Neurotoxicology 30, 326-329.
103. Giuliano, K. A., Johnston, P. A., Gough, A. et al. (2006). Systems cell biology based on high-content screening. Methods Enzymol. 414, 601-619. (Pubitemid 44716243)
104. Goldberg, A.M. (ed.) (1983). Alternative methods in toxicology, product safety evaluation. Vol. 1. New York: Mary Ann Liebert, Inc.
105. Gottmann, E., Kramer, S., Pfahringer, B. et al. (2001). Data quality in predictive toxicology: reproducibility of rodent carcinogenicity experiments. Environ. Health Perspect. 109, 509-514. (Pubitemid 32998809)
106. Grandjean, P. and Landrigan, P. J. (2006). Developmental neurotoxicity of industrial chemicals. Lancet 368, 2167-2178. (Pubitemid 44894541)
107. Greenhough, S., Medine, C. N. and Hay, D. C. (2010). Pluripotent stem cell derived hepatocyte like cells and their potential in toxicity screening. Toxicology 278, 250-255.
108. Griffith, L. G. and Swartz, M. A. (2006). Capturing complex 3D tissue physiology in vitro. Nat. Rev. Mol. Cell Biol. 7, 211-224.
109. Guguen-Guillouzo, C., Corlu, A. and Guillouzo, A. (2010). Stem cell-derived hepatocytes and their use in toxicology. Toxicology 270, 3-9.
110. Guillouzo, A. (1998). Liver cell models in in vitro toxicology. Environ. Health Perspect. 106, Suppl. 2, 511-532.
111. Haase, A., Olmer, R., Schwanke, K. et al. (2009). Generation of induced pluripotent stem cells from human cord blood. Cell Stem Cell 5, 434-441.
112. Harry, G. J., Billingsley, M., Bruinink, A. et al. (1998). In vitro techniques for the assessment of neurotoxicity. Environ. Health Perspect. 106, Suppl. 1, 131-158. (Pubitemid 28196041)
113. Harry, G. J. and Tiffany-Castiglioni, E. (2005). Evaluation of neurotoxic potential by use of in vitro systems. Expert Opin. Drug Metab. Toxicol. 1, 701-713.
114. Hartung, T. (2001). Three Rs potential in the development and quality control of pharmaceuticals. ALTEX 18, Suppl. 1, 3-13.
115. Hartung, T. (2008). Food for thought ... on animal tests. ALTEX 25, 3-16.
116. st century - mapping the road ahead. Toxicol. Sci. 109, 18-23.
117. Hartung, T. (2009b). Toxicology for the twenty-first century. Nature 460, 208-212.
118. Hartung, T. and Daston, G. (2009). Are in vitro tests suitable for regulatory use? Toxicol. Sci. 111, 233-237.
119. Hartung, T. and Hoffmann, S. (2009). Food for thought ... on in silico methods in toxicology. ALTEX 26, 155-166.
120. Hartung, T. (2010). Food for thought ... on alternative methods for chemical safety testing. ALTEX 27, 3-14.
121. Hashizume, T., Yoshitomi, S., Asahi, S. et al. (2009). In vitro micronucleus test in HepG2 transformants expressing a series of human cytochrome P450 isoforms with chemicals requiring metabolic activation. Mutat. Res. 677, 1-7.
122. Hay, D. C., Zhao, D., Fletcher, J. et al. (2008). Efficient differentiation of hepatocytes from human embryonic stem cells exhibiting markers recapitulating liver development in vivo. Stem Cells 26, 894-902.
123. Heijne, W. H., Kienhuis, A. S., van Ommen, B. et al. (2005). Systems toxicology: applications of toxicogenomics, transcriptomics, proteomics and metabolomics in toxicology. Expert Rev. Proteomics 2, 767-780. (Pubitemid 41492397)
124. Heinloth, A. N., Irwin, R. D., Boorman, G. A. et al. (2004). Gene expression profiling of rat livers reveals indicators of potential adverse effects. Toxicol. Sci. 80, 193-202. (Pubitemid 38967410)
125. Helmcke, K. J., Syversen, T., Miller, D. M., 3rd et al. (2009). Characterization of the effects of methylmercury on Caenorhabditis elegans. Toxicol. Appl. Pharmacol. 240, 265-272.
126. Helmcke, K. J., Avila, D. S. and Aschner, M. (2010). Utility of Caenorhabditis elegans in high throughput neurotoxicological research. Neurotoxicol. Teratol. 32, 62-67.
127. Hidaka, K., Lee, J. K., Kim, H. S. et al. (2003). Chamber-specific differentiation of Nkx2.5-positive cardiac precursor cells from murine embryonic stem cells. FASEB J. 17, 740-742.
128. Hieter, P. and Boguski, M. (1997). Functional genomics: it's all how you read it. Science 278, 601-602. (Pubitemid 27464949)
129. Hill, A. J., Teraoka, H., Heideman, W. et al. (2005). Zebrafish as a model vertebrate for investigating chemical toxicity. Toxicol. Sci. 86, 6-19. (Pubitemid 41511344)
130. Hoffmann, S. and Hartung, T. (2005). Diagnosis: toxic! - trying to apply approaches of clinical diagnostics and prevalence in toxicology considerations. Toxicol. Sci. 85, 422-428. (Pubitemid 40614273)
131. Hogberg, H. T., Kinsner-Ovaskainen, A., Hartung, T. et al. (2009). Gene expression as a sensitive endpoint to evaluate cell differentiation and maturation of the developing central nervous system in primary cultures of rat cerebellar granule cells (CGCs) exposed to pesticides. Toxicol. Appl. Pharmacol. 235, 268-286.
132. Hogberg, H. T., Kinsner-Ovaskainen, A., Coecke, S. et al. (2010). mRNA expression is a relevant tool to identify developmental neurotoxicants using an in vitro approach. Toxicol. Sci. 113, 95-115.
133. Honegger, P., Lenoir, D. and Favrod, P. (1979). Growth and differentiation of aggregating fetal brain cells in a serum-free defined medium. Nature 282, 305-308. (Pubitemid 10198527)
134. Honegger, P. and Schilter, B. (1992). Serum free aggregate cultures of foetal rat brain and liver cells: methodology and some practical applications in neurotoxicology. In G. Zbinden (ed.), The brain and bits and pieces: In vitro techniques in neurobiology, neuropharmacology and neurotoxicology (51-79). Zollikon, Switzerland: MTC Verlag.
135. Honegger, P. and Monnet-Tschudi, F. (2001). Aggregating neural cell cultures. In S. Fedoroff and A. Richardson (eds.), Protocols for Neural Cell Culture. (3rd ed., 199-218). Totowa, N.J.: Humana Press.
136. Houck, K. A. and Kavlock, R. J. (2008). Understanding mechanisms of toxicity: insights from drug discovery research. Toxicol. Appl. Pharmacol. 227, 163-178. (Pubitemid 351233054)
137. Hu, B. Y., Weick, J. P., Yu, J. et al. (2010). Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc. Natl. Acad. Sci. U S A 107, 4335-4340.
138. Ideker, T., Galitski, T. and Hood, L. (2001). A new approach to decoding life: systems biology. Annu. Rev. Genomics Hum. Genet. 2, 343-372. (Pubitemid 35265011)
139. Jadhav, K. B. and Rajini, P. S. (2009). Evaluation of sublethal effects of dichlorvos upon Caenorhabditis elegans based on a set of end points of toxicity. J. Biochem. Mol. Toxicol. 23, 9-17.
140. James, P. (1997). Protein identification in the post-genome era: the rapid rise of proteomics. Q. Rev. Biophys. 30, 279-331.
141. Jaworska, J., Gabbert, S. and Aldenberg, T. (2010). Towards optimization of chemical testing under REACH: a Bayesian network approach to Integrated Testing Strategies. Regul. Toxicol. Pharmacol. 57, 157-167.
142. Jirova, D., Basketter, D., Liebsch, M. et al. (2010). Comparison of human skin irritation patch test data with in vitro skin irritation assays and animal data. Contact Dermatitis 62, 109-116.
143. Judson, R. S., Houck, K. A., Kavlock, R. J. et al. (2010). In vitro screening of environmental chemicals for targeted testing prioritization: the ToxCast project. Environ. Health Perspect. 118, 485-492.
144. Kaletta, T. and Hengartner, M. O. (2006). Finding function in novel targets: C. elegans as a model organism. Nat. Rev. Drug Discov. 5, 387-398.
145. Kammili, R. K., Taylor, D. G., Xia, J. et al. (2010). Generation of novel reporter stem cells and their application for molecular imaging of cardiac-differentiated stem cells in vivo. Stem Cells Dev. 19, 1437-1448.
146. Kandarova, H., Liebsch, M., Schmidt, E. et al. (2006). Assessment of the skin irritation potential of chemicals by using the SkinEthic reconstructed human epidermal model and the common skin irritation protocol evaluated in the ECVAM skin irritation validation study. ATLA 34, 393-406. (Pubitemid 44369441)
147. Kari, G., Rodeck, U. and Dicker, A. P. (2007). Zebrafish: an emerging model system for human disease and drug discovery. Clin. Pharmacol. Ther. 82, 70-80. (Pubitemid 46944200)
148. Katagiri, F. and Glazebrook, J. (2009). Overview of mRNA expression profiling using DNA microarrays. Curr. Protoc. Mol. Biol. Chapter 22, Unit 22 24.
149. Kehat, I., Amit, M., Gepstein, A. et al. (2003). Development of cardiomyocytes from human ES cells. Methods Enzymol. 365, 461-473. (Pubitemid 37531567)
150. Kennedy, S. (2002). The role of proteomics in toxicology: identification of biomarkers of toxicity by protein expression analysis. Biomarkers 7, 269-290.
151. Kikkawa, R., Yamamoto, T., Fukushima, T. et al. (2005). Investigation of a hepatotoxicity screening system in primary cell cultures - "what biomarkers would need to be addressed to estimate toxicity in conventional and new approaches?". J. Toxicol. Sci. 30, 61-72. (Pubitemid 40410215)
152. Kikkawa, R., Fujikawa, M., Yamamoto, T. et al. (2006). In vivo hepatotoxicity study of rats in comparison with in vitro hepa totoxicity screening system. J. Toxicol. Sci. 31, 23-34. (Pubitemid 43375666)
153. Kim, J. H., Auerbach, J. M., Rodriguez-Gomez, J. A. et al. (2002). Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature 418, 50-56. (Pubitemid 34742566)
154. Kim, S. and Misra, A. (2007). SNP genotyping: technologies and biomedical applications. Annu. Rev. Biomed. Eng. 9, 289-320. (Pubitemid 350246659)
155. Kinsner-Ovaskainen, A., Akkan, Z., Casati, S. et al. (2009). Overcoming barriers to validation of non-animal partial replacement methods/Integrated Testing Strategies: the report of an EPAA-ECVAM workshop. ATLA 37, 437-444.
156. Kirchhoff, F., Dringen, R. and Giaume, C. (2001). Pathways of neuron-astrocyte interactions and their possible role in neuroprotection. Eur. Arch. Psychiatry Clin. Neurosci. 251, 159-169. (Pubitemid 32963493)
157. Kitano, H. (2002). Systems biology: a brief overview. Science 295, 1662-1664.
158. Klohs, J., Wunder, A. and Licha, K. (2008). Near-infrared fluorescent probes for imaging vascular pathophysiology. Basic Res. Cardiol. 103, 144-151. (Pubitemid 351356756)
159. Knight, A. (2007). Animal experiments scrutinised: systematic reviews demonstrate poor human clinical and toxicological utility. ALTEX 24, 320-325.
160. st century: implications for human health risk assessment. Risk Anal. 29, 474-479.
161. Kronick, M. N. (2004). Creation of the whole human genome microarray. Expert Rev. Proteomics 1, 19-28.
162. Kuegler, P. B., Zimmer, B., Waldmann, T. et al. (2010). Markers of murine embryonic and neural stem cells, neurons and astrocytes: reference points for developmental neurotoxicity testing. ALTEX 27, 17-42.
163. Lagido, C., McLaggan, D., Flett, A. et al. (2009). Rapid sublethal toxicity assessment using bioluminescent Caenorhabditis elegans, a novel whole-animal metabolic biosensor. Toxicol. Sci. 109, 88-95.
164. Lanza, I. R., Zhang, S., Ward, L. E. et al. (2010). Quantitative metabolomics by H-NMR and LC-MS/MS confirms altered metabolic pathways in diabetes. PLoS One 5, e10538.
165. Lavon, N. (2010). Generation of hepatocytes from human embryonic stem cells. Methods Mol. Biol. 640, 237-246.
166. Lee, J., Cuddihy, M. J. and Kotov, N. A. (2008). Three-dimensional cell culture matrices: state of the art. Tissue Eng. Part B Rev. 14, 61-86.
167. Lee, D. Y. and Li, K. C. (2009). Systems diagnostics: the systems approach to molecular imaging. AJR Am. J. Roentgenol. 193, 287-294.
168. Lee, C. J., Spalding, A. C., Ben-Josef, E. et al. (2010). In vivo bioluminescent imaging of irradiated orthotopic pancreatic cancer xenografts in nonobese diabetic-severe combined immunodeficient mice: a novel method for targeting and assaying efficacy of ionizing radiation. Transl. Oncol. 3, 153-159.
169. Leist, M., Bremer, S., Brundin, P. et al. (2008). The biological and ethical basis of the use of human embryonic stem cells for in vitro test systems or cell therapy. ALTEX 25, 163-190.
170. Leung, M. C., Williams, P. L., Benedetto, A. et al. (2008). Caenorhabditis elegans: an emerging model in biomedical and environmental toxicology. Toxicol. Sci. 106, 5-28.
171. Li, W., Lam, M., Choy, D. et al. (2006). Human primary renal cells as a model for toxicity assessment of chemo-therapeutic drugs. Toxicol. In Vitro 20, 669-676. (Pubitemid 43816247)
172. Li, Y., Kang, X., Guo, K. et al. (2009). Proteome alteration of early-stage differentiation of mouse embryonic stem cells into hepatocyte-like cells. Electrophoresis 30, 1431-1440.
173. Li, J., Tao, R., Wu, W. et al. (2010). 3D PLGA scaffolds improve differentiation and function of bone marrow mesenchymal stem cell-derived hepatocytes. Stem Cells Dev. 19, 1427-1436.
174. Lindon, J. C., Keun, H. C., Ebbels, T. M. et al. (2005). The Consortium for Metabonomic Toxicology (COMET): aims, activities and achievements. Pharmacogenomics 6, 691-699. (Pubitemid 41479414)
175. Liu, A. M., New, D. C., Lo, R. K. et al. (2009). Reporter gene assays. Methods Mol. Biol. 486, 109-123.
176. Liu, T., Zhang, S., Chen, X. et al. (2010). Hepatic differentiation of mouse embryonic stem cells in three-dimensional polymer scaffolds. Tissue Eng. Part A 16, 1115-1122.
177. Lockhart, D. J., Dong, H., Byrne, M. C. et al. (1996). Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat. Biotechnol. 14, 1675-1680. (Pubitemid 26414810)
178. Logeart-Avramoglou, D., Oudina, K., Bourguignon, M. et al. (2010). In vitro and in vivo bioluminescent quantification of viable stem cells in engineered constructs. Tissue Eng. Part C Methods 16, 447-458.
179. Lu, B. (2009). Recent advances in using Drosophila to model neurodegenerative diseases. Apoptosis 14, 1008-1020.
180. Ludwig, T. E., Bergendahl, V., Levenstein, M. E. et al. (2006). Feeder-independent culture of human embryonic stem cells. Nat. Methods 3, 637-646. (Pubitemid 44123431)
181. Luker, G. D., Bardill, J. P., Prior, J. L. et al. (2002). Noninvasive bioluminescence imaging of herpes simplex virus type 1 infection and therapy in living mice. J. Virol. 76, 12149-12161. (Pubitemid 35304313)
182. Luker, G. D. and Luker, K. E. (2008a). Optical imaging: current applications and future directions. J. Nucl. Med. 49, 1-4.
183. Luker, K. E. and Luker, G. D. (2008b). Applications of bioluminescence imaging to antiviral research and therapy: multiple luciferase enzymes and quantitation. Antiviral Res. 78, 179-187.
184. Luker, K. E. and Luker, G. D. (2010). Bioluminescence imaging of reporter mice for studies of infection and inflammation. Antiviral Res. 86, 93-100.
185. st century: a view from the pharmaceutical industry. Toxicol. Sci. 110, 40-46.
186. Maggioli, J., Hoover, A. and Weng, L. (2006). Toxicogenomic analysis methods for predictive toxicology. J. Pharmacol. Toxicol. Methods 53, 31-37. (Pubitemid 43052701)
187. Malstrom, S. E., Jekic-McMullen, D., Sambucetti, L. et al. (2004). In vivo bioluminescent monitoring of chemical toxicity using heme oxygenase-luciferase transgenic mice. Toxicol. Appl. Pharmacol. 200, 219-228. (Pubitemid 39422421)
188. Mann, M. and Jensen, O. N. (2003). Proteomic analysis of post-translational modifications. Nat. Biotechnol. 21, 255-261. (Pubitemid 36314808)
189. Mardis, E. R. (2008). Next-generation DNA sequencing methods. Annu. Rev. Genomics Hum. Genet. 9, 387-402.
190. Mathijs, K., Kienhuis, A. S., Brauers, K. J. et al. (2009). Assessing the metabolic competence of sandwich-cultured mouse primary hepatocytes. Drug Metab. Dispos. 37, 1305-1311.
191. Mayr, L. M. and Bojanic, D. (2009). Novel trends in high-throughput screening. Curr. Opin. Pharmacol. 9, 580-588.
192. Mazzoleni, G., Di Lorenzo, D. and Steimberg, N. (2009). Modelling tissues in 3D: the next future of pharmaco-toxicology and food research? Genes. Nutr. 4, 13-22.
193. McKusick, V. A. (1997). Genomics: structural and functional studies of genomes. Genomics 45, 244-249.
194. st century in a regulatory context: another Ames test? ... or a new edition of "the Red Book"? Toxicol. Sci. 108, 19-21.
195. Merkel, J. S., Michaud, G. A., Salcius, M. et al. (2005). Functional protein microarrays: just how functional are they? Curr. Opin. Biotechnol. 16, 447-452. (Pubitemid 41114851)
196. Miranda, J. P., Rodrigues, A., Tostoes, R. M. et al. (2010). Extending hepatocyte functionality for drug-testing applications using high-viscosity alginate-encapsulated three-dimensional cultures in bioreactors. Tissue Eng. Part C Methods 16, 1223-1232.
197. Mishra, K. P., Ganju, L., Sairam, M. et al. (2008). A review of high throughput technology for the screening of natural products. Biomed. Pharmacother. 62, 94-98. (Pubitemid 351215811)
198. Monnet-Tschudi, F., Zurich, M. G. and Honegger, P. (1996). Comparison of the developmental effects of two mercury compounds on glial cells and neurons in aggregate cultures of rat telencephalon. Brain Res. 741, 52-59. (Pubitemid 26426297)
199. Monnet-Tschudi, F., Zurich, M. G. and Honegger, P. (2007). Neurotoxicant-induced inflammatory response in three-dimensional brain cell cultures. Hum. Exp. Toxicol. 26, 339-346. (Pubitemid 46733357)
200. Moon, Y. J., Lee, M. W., Yoon, H. H. et al. (2008). Hepatic differentiation of cord blood-derived multipotent progenitor cells (MPCs) in vitro. Cell Biol. Int. 32, 1293-1301.
201. Moors, M., Rockel, T. D., Abel, J. et al. (2009). Human neurospheres as three-dimensional cellular systems for developmental neurotoxicity testing. Environ. Health Perspect. 117, 1131-1138.
202. Morisseau, C., Merzlikin, O., Lin, A. et al. (2009). Toxicology in the fast lane: application of high-throughput bioassays to detect modulation of key enzymes and receptors. Environ. Health Perspect. 117, 1867-1872.
203. Morley, E. J., Hirsch, H. V., Hollocher, K. et al. (2003). Effects of chronic lead exposure on the neuromuscular junction in Drosophila larvae. Neurotoxicology 24, 35-41. (Pubitemid 36091159)
204. Morris, M. C. (2010). Fluorescent biosensors of intracellular targets from genetically encoded reporters to modular polypeptide probes. Cell Biochem. Biophys. 56, 19-37.
205. Mun, G. C., Aardema, M. J., Hu, T. et al. (2009). Further development of the EpiDerm 3D reconstructed human skin micronucleus (RSMN) assay. Mutat. Res. 673, 92-99.
206. Navarro-Alvarez, N., Soto-Gutierrez, A., Yuasa, T. et al. (2008). Long-term culture of Japanese human embryonic stem cells in feeder-free conditions. Cell Transplant. 17, 27-33. (Pubitemid 351551377)
207. Netzlaff, F., Lehr, C. M., Wertz, P. W. et al. (2005). The human epidermis models EpiSkin, SkinEthic and EpiDerm: an evaluation of morphology and their suitability for testing phototoxicity, irritancy, corrosivity, and substance transport. Eur. J. Pharm. Biopharm. 60, 167-178. (Pubitemid 40804559)
208. Nichols, C. D. (2006). Drosophila melanogaster neurobiology, neuropharmacology, and how the fly can inform central nervous system drug discovery. Pharmacol. Ther. 112, 677-700.
209. Nicholson, J. K. and Lindon, J. C. (2008). Systems biology: Metabonomics. Nature 455, 1054-1056.
210. Niederlein, A., Meyenhofer, F., White, D. et al. (2009). Image analysis in high-content screening. Comb. Chem. High Throughput Screen. 12, 899-907.
211. Nishikawa, S., Jakt, L. M. and Era, T. (2007). Embryonic stem-cell culture as a tool for developmental cell biology. Nat. Rev. Mol. Cell Biol. 8, 502-507. (Pubitemid 46809158)
212. NRC (2000). Scientific frontiers in developmental toxicology and risk assessment. Washington, DC: National Academy Press.
213. NRC (2007). Toxicity testing in the 21st century: a vision and a strategy. Washington, DC: National Academy Press.
214. Ntziachristos, V., Bremer, C. and Weissleder, R. (2003). Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging. Eur. Radiol. 13, 195-208. (Pubitemid 36790510)
215. O'Brien, P. J., Irwin, W., Diaz, D. et al. (2006). High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening. Arch. Toxicol. 80, 580-604. (Pubitemid 44214526)
216. O'Malley, J., Woltjen, K. and Kaji, K. (2009). New strategies to generate induced pluripotent stem cells. Curr. Opin. Biotechnol. 20, 516-521.
217. O'Rourke, E. J., Conery, A. L. and Moy, T. I. (2009). Whole-animal high-throughput screens: the C. elegans model. Methods Mol. Biol. 486, 57-75.
218. Oba, Y., Ojika, M. and Inouye, S. (2003). Firefly luciferase is a bifunctional enzyme: ATP-dependent monooxygenase and a long chain fatty acyl-CoA synthetase. FEBS Lett. 540, 251-254. (Pubitemid 36398066)
219. Olson, H., Betton, G., Robinson, D. et al. (2000). Concordance of the toxicity of pharmaceuticals in humans and in animals. Regul. Toxicol. Pharmacol. 32, 56-67.
220. th HUPO World Congress of Proteomics: launching the second phase of the HUPOPlasma Proteome Project (PPP-2) 16-20 August 2008, Amsterdam, The Netherlands. Proteomics 9, 4-6.
221. Ortiz, J. G., Opoka, R., Kane, D. et al. (2009). Investigating arsenic susceptibility from a genetic perspective in Drosophila reveals a key role for glutathione synthetase. Toxicol. Sci. 107, 416-426.
222. Osman, A. M., van Dartel, D. A., Zwart, E. et al. (2010). Proteome profiling of mouse embryonic stem cells to define markers for cell differentiation and embryotoxicity. Reprod. Toxicol. 30, 322-332.
223. Pampaloni, F., Stelzer, E. H. and Masotti, A. (2009). Three-dimensional tissue models for drug discovery and toxicology. Recent Pat. Biotechnol. 3, 103-117.
224. Parng, C., Roy, N. M., Ton, C. et al. (2007). Neurotoxicity assessment using zebrafish. J. Pharmacol. Toxicol. Methods 55, 103-112. (Pubitemid 46048678)
225. Pauli, J., Vag, T., Haag, R. et al. (2009). An in vitro characterization study of new near infrared dyes for molecular imaging. Eur. J. Med. Chem. 44, 3496-3503.
226. Peterson, R. T., Nass, R., Boyd, W. A. et al. (2008). Use of non-mammalian alternative models for neurotoxicological study. Neurotoxicology 29, 546-555.
227. Pfaller, W. and Gstraunthaler, G. (1998). Nephrotoxicity testing in vitro - what we know and what we need to know. Environ. Health Perspect. 106, Suppl. 2, 559-569. (Pubitemid 28256763)
228. st century: a vision and a strategy". Hum. Exp. Toxicol. 29, 11-14.
229. Phizicky, E., Bastiaens, P. I., Zhu, H. et al. (2003). Protein analysis on a proteomic scale. Nature 422, 208-215. (Pubitemid 36362758)
230. Pittenger, M. F. (2008). Mesenchymal stem cells from adult bone marrow. Methods Mol. Biol. 449, 27-44.
231. Pourahmad, J., Hosseini, M. J., Eskandari, M. R. et al. (2010). Mitochondrial/lysosomal toxic cross-talk plays a key role in cisplatin nephrotoxicity. Xenobiotica 40, 763-771.
232. Purcell, W. M., Atterwill, C. K. and Xu, J. (2003). Cryopreservation of organotypic brain spheroid cultures. ATLA 31, 563-573. (Pubitemid 38220454)
233. Radio, N. M., Breier, J. M., Shafer, T. J. et al. (2008). Assessment of chemical effects on neurite outgrowth in PC12 cells using high content screening. Toxicol. Sci. 105, 106-118.
234. Rambhatla, L., Chiu, C. P., Kundu, P. et al. (2003). Generation of hepatocyte-like cells from human embryonic stem cells. Cell Transplant. 12, 1-11. (Pubitemid 36397310)
235. Rand, M. D., Dao, J. C. and Clason, T. A. (2009). Methylmercury disruption of embryonic neural development in Drosophila. Neurotoxicology 30, 794-802.
236. Rand, M. D. (2010). Drosophotoxicology: the growing potential for Drosophila in neurotoxicology. Neurotoxicol. Teratol. 32, 74-83.
237. Robertson, D. G. (2005). Metabonomics in toxicology: a review. Toxicol. Sci. 85, 809-822.
238. Ross, P. L., Huang, Y. N., Marchese, J. N. et al. (2004). Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol. Cell Proteomics 3, 1154-1169.
239. 4). ALTEX 26, 187-208.
240. Russom, C. L., Breton, R. L., Walker, J. D. et al. (2003). An overview of the use of quantitative structure-activity relationships for ranking and prioritizing large chemical inventories for environmental risk assessments. Environ. Toxicol. Chem. 22, 1810-1821. (Pubitemid 37337306)
241. Sadikot, R. T. and Blackwell, T. S. (2005). Bioluminescence imaging. Proc. Am. Thorac. Soc. 2, 537-540, 511-532.
242. Sadikot, R. T. and Blackwell, T. S. (2008). Bioluminescence: imaging modality for in vitro and in vivo gene expression. Methods Mol. Biol. 477, 383-394.
243. Sanger, F., Nicklen, S. and Coulson, A. R. (1977). DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. U S A 74, 5463-5467.
244. Schardein, J. L., Schwetz, B. A. and Kenel, M. F. (1985). Species sensitivities and prediction of teratogenic potential. Environ. Health Perspect. 61, 55-67. (Pubitemid 16221990)
245. Schena, M., Shalon, D., Davis, R. W. et al. (1995). Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270, 467-470.
246. Schettler, T. (2001). Toxic threats to neurologic development of children. Environ. Health Perspect. 109, Suppl. 6, 813-816.
247. Schmidt, C. W. (2009). TOX 21: new dimensions of toxicity testing. Environ. Health Perspect. 117, A348-353.
248. Schoonen, W. G., Westerink, W. M. and Horbach, G. J. (2009). High-throughput screening for analysis of in vitro toxicity. EXS 99, 401-452.
249. Schulz, T. C., Noggle, S. A., Palmarini, G. M. et al. (2004). Differentiation of human embryonic stem cells to dopaminergic neurons in serum-free suspension culture. Stem Cells 22, 1218-1238. (Pubitemid 39636400)
250. Schuster, S. C. (2008). Next-generation sequencing transforms today's biology. Nat. Methods 5, 16-18.
251. st century: a vision and a strategy". Hum. Exp. Toxicol. 29, 15-19.
252. st century: a global call to action. Toxicol. In Vitro 23, 1576-1579.
253. Smith, C. A., O'Maille, G., Want, E. J. et al. (2005). METLIN: a metabolite mass spectral database. Ther. Drug Monit. 27, 747-751. (Pubitemid 44391729)
254. Smits, A. M., van Vliet, P., Metz, C. H. et al. (2009). Human cardiomyocyte progenitor cells differentiate into functional mature cardiomyocytes: an in vitro model for studying human cardiac physiology and pathophysiology. Nat. Protoc. 4, 232-243.
255. Sokolowski, M. B. (2001). Drosophila: genetics meets behaviour. Nat. Rev. Genet. 2, 879-890.
256. Soto-Gutierrez, A., Navarro-Alvarez, N., Caballero-Corbalan, J. et al. (2008). Endoderm induction for hepatic and pancreatic differentiation of ES cells. Acta Med. Okayama 62, 63-68.
257. Spielmann, H., Seiler, A., Bremer, S. et al. (2006). The practical application of three validated in vitro embryotoxicity tests. The report and recommendations of an ECVAM/ZEBET workshop (ECVAM workshop 57). ATLA 34, 527-538.
258. Steel, D., Hyllner, J. and Sartipy, P. (2009). Cardiomyocytes derived from human embryonic stem cells - characteristics and utility for drug discovery. Curr. Opin. Drug Discov. Devel. 12, 133-140.
259. Stevens, J. L. (2006). Future of toxicology - mechanisms of toxicity and drug safety: where do we go from here? Chem. Res. Toxicol. 19, 1393-1401.
260. Stevens, M. M. (2009). Toxicology: Testing in the third dimension. Nat. Nanotechnol. 4, 342-343.
261. Stoevesandt, O., Taussig, M. J. and He, M. (2009). Protein microarrays: high-throughput tools for proteomics. Expert Rev. Proteomics 6, 145-157.
262. Strauss, V., Wiemer, J., Leibold, E. et al. (2009). Influence of strain and sex on the metabolic profile of rats in repeated dose toxicological studies. Toxicol. Lett. 191, 88-95.
263. Sullivan, G. J., Hay, D. C., Park, I. H. et al. (2010). Generation of functional human hepatic endoderm from human induced pluripotent stem cells. Hepatology 51, 329-335.
264. Sumner, S., Snyder, R., Burgess, J. et al. (2009). Metabolomics in the assessment of chemical-induced reproductive and developmental outcomes using non-invasive biological fluids: application to the study of butylbenzyl phthalate. J. Appl. Toxicol. 29, 703-714.
265. Suzuki, T., Matsuzaki, T., Hagiwara, H. et al. (2007). Recent advances in fluorescent labeling techniques for fluorescence microscopy. Acta Histochem. Cytochem. 40, 131-137.
266. Swedlow, J. R. and Platani, M. (2002). Live cell imaging using wide-field microscopy and deconvolution. Cell Struct. Funct. 27, 335-341. (Pubitemid 36149987)
267. Swistowski, A., Peng, J., Liu, Q. et al. (2010). Efficient generation of functional dopaminergic neurons from human induced pluripotent stem cells under defined conditions. Stem Cells 28, 1893-1904.
268. Takahashi, K. and Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676. (Pubitemid 44233629)
269. Tanaka, H. (2010). Omics-based medicine and systems pathology. A new perspective for personalized and predictive medicine. Methods Inf. Med. 49, 173-185.
270. Thomas, R. S., Rank, D. R., Penn, S. G. et al. (2002). Application of genomics to toxicology research. Environ. Health Perspect. 110, Suppl. 6, 919-923. (Pubitemid 36204283)
271. Thongboonkerd, V. (2008). Urinary proteomics: towards biomarker discovery, diagnostics and prognostics. Mol. Biosyst. 4, 810-815.
272. Tiffany-Castiglioni, E., Ehrich, M., Dees, L. et al. (1999). Bridging the gap between in vitro and in vivo models for neurotoxicology. Toxicol. Sci. 51, 178-183. (Pubitemid 29496224)
273. Tinois, E., Tiollier, J., Gaucherand, M. et al. (1991). In vitro and post-transplantation differentiation of human keratinocytes grown on the human type IV collagen film of a bilayered dermal substitute. Exp. Cell Res. 193, 310-319. (Pubitemid 121005671)
274. Toh, Y. C., Lim, T. C., Tai, D. et al. (2009). A microfluidic 3D hepatocyte chip for drug toxicity testing. Lab. Chip 9, 2026-2035.
275. Trujillo, E., Davis, C. and Milner, J. (2006). Nutrigenomics, proteomics, metabolomics, and the practice of dietetics. J. Am. Diet. Assoc. 106, 403-413. (Pubitemid 43288017)
276. Truman, J. W. and Bate, M. (1988). Spatial and temporal patterns of neurogenesis in the central nervous system of Drosophila melanogaster. Dev. Biol. 125, 145-157. (Pubitemid 18021746)
277. Truman, J. W. (1990). Metamorphosis of the central nervous system of Drosophila. J. Neurobiol. 21, 1072-1084.
278. Tuschl, G., Hrach, J., Walter, Y. et al. (2009). Serum-free collagen sandwich cultures of adult rat hepatocytes maintain liver-like properties long term: a valuable model for in vitro toxicity and drug-drug interaction studies. Chem. Biol. Interact. 181, 124-137.
279. Ullmann, K., Wiencierz, A. M., Muller, C. et al. (2008). A high-throughput reporter gene assay to prove the ability of natural compounds to modulate glutathione peroxidase, superoxide dismutase and catalase gene promoters in V79 cells. Free Radic. Res. 42, 746-753.
280. Ullrich, A., Stolz, D. B., Ellis, E. C. et al. (2009). Long term cultures of primary human hepatocytes as an alternative to drug testing in animals. ALTEX 26, 295-302.
281. Uroukov, I. S., Ma, M., Bull, L. et al. (2006). Electrophysiological measurements in three-dimensional in vivo-mimetic organotypic cell cultures: preliminary studies with hen embryo brain spheroids. Neurosci. Lett. 404, 33-38. (Pubitemid 44041772)
282. Usami, M., Mitsunaga, K., Nakazawa, K. et al. (2008). Proteomic analysis of selenium embryotoxicity in cultured postimplantation rat embryos. Birth Defects Res. B Dev. Reprod. Toxicol. 83, 80-96. (Pubitemid 351631342)
283. US EPA (1998a). Health effects guidelines OPPTS 870.6300 developmental neurotoxicity study. http://www.epa.gov/ocspp/pubs/frs/publications/Test- Guidelines/series870.htm
284. US EPA (1998b). Chemical hazard data availability study. What do we really know about the safety of high production volume chemicals? http://www.epa.gov/chemrtk/pubs/general/hazchem.pdf
285. Vallier, L., Touboul, T., Brown, S. et al. (2009). Signaling pathways controlling pluripotency and early cell fate decisions of human induced pluripotent stem cells. Stem Cells 27, 2655-2666.
286. van Dartel, D. A., Pennings, J. L., van Schooten, F. J. et al. (2010b). Transcriptomics-based identification of developmental toxicants through their interference with cardiomyocyte differentiation of embryonic stem cells. Toxicol. Appl. Pharmacol. 243, 420-428.
287. van Dartel, D. A., Pennings, J. L., De la Fonteyne, L. J. et al. (2010a). Monitoring developmental toxicity in the embryonic stem cell test using differential gene expression of differentiation-related genes. Toxicol. Sci. 116, 130-139.
288. van Delft, J. H., van Agen, E., van Breda, S. G. et al. (2005). Comparison of supervised clustering methods to discriminate genotoxic from non-genotoxic carcinogens by gene expression profiling. Mutat. Res. 575, 17-33.
289. van Hoof, D., Heck, A. J., Krijgsveld, J. et al. (2008). Proteomics and human embryonic stem cells. Stem Cell Res. 1, 169-182.
290. van Ravenzwaay, B., Cunha, G. C., Leibold, E. et al. (2007). The use of metabolomics for the discovery of new biomarkers of effect. Toxicol. Lett. 172, 21-28. (Pubitemid 47161053)
291. van Vliet, E., Morath, S., Eskes, C. et al. (2008). A novel in vitro metabolomics approach for neurotoxicity testing, proof of principle for methyl mercury chloride and caffeine. Neurotoxicology 29, 1-12.
292. van Vliet, E., Stoppini, L., Balestrino, M. et al. (2007). Electro physiological recording of re-aggregating brain cell cultures on multi-electrode arrays to detect acute neurotoxic effects. Neurotoxicology 28, 1136-1146. (Pubitemid 350026589)
293. VanMeter, A., Signore, M., Pierobon, M. et al. (2007). Reverse-phase protein microarrays: application to biomarker discovery and translational medicine. Expert Rev. Mol. Diagn. 7, 625-633. (Pubitemid 47547727)
294. Vendrell, I., Carrascal, M., Campos, F. et al. (2010). Methylmercury disrupts the balance between phosphorylated and non-phosphorylated cofilin in primary cultures of mice cerebellar granule cells. A proteomic study. Toxicol. Appl. Pharmacol. 242, 109-118.
295. Vereyken, E. J., Fluitsma, D. M., Bolijn, M. J. et al. (2009). An in vitro model for de- and remyelination using lysophosphatidyl choline in rodent whole brain spheroid cultures. Glia 57, 1326-1340.
296. st century: a vision and a strategy". Hum. Exp. Toxicol. 29, 31-32.
297. Walgren, R. A. and McLeod, H. L. (2005). Small inhibitory RNA - a tool for credentialing candidate genes. Pharmaco-genomics 6, 281-292. (Pubitemid 40601631)
298. Walker, T. M., Davenport-Jones, J. E., Fox, R. M. et al. (1999). The neurotoxic effects of methylenedioxymethamphetamine (MDMA) and its metabolites on rat brain spheroids in culture. Cell Biol. Toxicol. 15, 137-142. (Pubitemid 29518614)
299. Walker, N. J. (2001). Real-time and quantitative PCR: applications to mechanism-based toxicology. J. Biochem. Mol. Toxicol. 15, 121-127.
300. Walker, J. D. and Carlsen, L. (2002). QSARs for identifying and prioritizing substances with persistence and bioconcentration potential. SAR QSAR Environ. Res. 13, 713-725.
301. Wang, S., Nagrath, D., Chen, P. C. et al. (2008). Three-dimensional primary hepatocyte culture in synthetic self-assembling peptide hydrogel. Tissue Eng. Part A 14, 227-236.
302. Waters, M. D. and Fostel, J. M. (2004). Toxicogenomics and systems toxicology: aims and prospects. Nat. Rev. Genet. 5, 936-948. (Pubitemid 39564256)
303. Waters, M. D., Jackson, M. and Lea, I. (2010). Characterizing and predicting carcinogenicity and mode of action using conventional and toxicogenomics methods. Mutat. Res. 705, 184-200.
304. Wegner, B., Baer, P., Gauer, S. et al. (2005). Caspofungin is less nephrotoxic than amphotericin B in vitro and predominantly damages distal renal tubular cells. Nephrol. Dial. Transplant. 20, 2071-2079. (Pubitemid 41510080)
305. Wen, J., Xia, Q., Lu, C. et al. (2007). Proteomic analysis of cardiomyocytes differentiation in mouse embryonic carcinoma P19CL6 cells. J. Cell Biochem. 102, 149-160. (Pubitemid 47378918)
306. West, P. R., Weir, A. M., Smith, A. M. et al. (2010). Predicting human developmental toxicity of pharmaceuticals using human embryonic stem cells and metabolomics. Toxicol. Appl. Pharmacol. 247, 18-27.
307. Wetmore, B. A. and Merrick, B. A. (2004). Toxicoproteomics: proteomics applied to toxicology and pathology. Toxicol. Pathol. 32, 619-642. (Pubitemid 39491933)
308. Williams, P. L., Anderson, G. L., Johnstone, J. L. et al. (2000). Caenorhabditis elegans as an alternative animal species. J. Toxicol. Environ. Health A 61, 641-647.
309. Wilson, K., Yu, J., Lee, A. et al. (2008). In vitro and in vivo bioluminescence reporter gene imaging of human embryonic stem cells. J. Vis Exp. 14, pii 740.
310. Wishart, D. S. (2007). Human Metabolome Database: completing the 'human parts list'. Pharmacogenomics 8, 683-686.
311. Xing, X., Du, M., Zhang, Y. et al. (2009). Adverse effects of metal exposure on chemotaxis towards water-soluble attractants regulated mainly by ASE sensory neuron in nematode Caenorhabditis elegans. J. Environ. Sci. (China) 21, 1684-1694.
312. Yamashita, A., Nishikawa, S. and Rancourt, D. E. (2010). Identification of five developmental processes during chondrogenic differentiation of embryonic stem cells. PLoS One 5, e10998.
313. Yan, Y., Yang, D., Zarnowska, E. D. et al. (2005). Directed differentiation of dopaminergic neuronal subtypes from human embryonic stem cells. Stem Cells 23, 781-790. (Pubitemid 40791793)
314. Yang, L., Ho, N. Y., Alshut, R. et al. (2009). Zebrafish embryos as models for embryotoxic and teratological effects of chemicals. Reprod. Toxicol. 28, 245-253.
315. Yoshitomi, S., Ikemoto, K., Takahashi, J. et al. (2001). Establishment of the transformants expressing human cytochrome P450 subtypes in HepG2, and their applications on drug metabolism and toxicology. Toxicol. In Vitro 15, 245-256. (Pubitemid 32476834)
316. Yu, J., Vodyanik, M. A., Smuga-Otto, K. et al. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917-1920.
317. Zanella, F., Lorens, J. B. and Link, W. (2010). High content screening: seeing is believing. Trends Biotechnol. 28, 237-245.
318. Zbinden, G. (1990a). In vitro methods, past successes and future challenges. Acta Physiol. Scand., Suppl. 592, 9-12.
319. Zbinden, G. (1990b). [Alternative methods, the present and future]. Therapie 45, 347-350.
320. Zhang, J., Wilson, G. F., Soerens, A. G. et al. (2009). Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ. Res. 104, e30-41.
321. Zidek, N., Hellmann, J., Kramer, P. J. et al. (2007). Acute hepatotoxicity: a predictive model based on focused illumina microarrays. Toxicol. Sci. 99, 289-302. (Pubitemid 47250386)
322. Zock, J. M. (2009). Applications of high content screening in life science research. Comb. Chem. High Throughput Screen 12, 870-876.
323. Zurich, M. G., Honegger, P., Schilter, B. et al. (2004). Involvement of glial cells in the neurotoxicity of parathion and chlorpyrifos. Toxicol. Appl. Pharmacol. 201, 97-104 (Pubitemid 39487157)